Bharat Biotech has partnered with GSK to advance the Shigella vaccine altSonflex1-2-3. With strong early trial results and no ...

The altSonflex1-2-3 vaccine candidate, developed by GSK and now advancing through a strategic collaboration with Bharat Biotech, represents one of the most advanced Shigella vaccine candidates ...

Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and manufacturing, announced on Thursday that it has partnered with GSK plc, a global biopharma company, for the ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Bharat Biotech joins GSK to develop a Shigella vaccine to fight shigellosis in children, with Phase 3 trials underway and ...

For the first time, Fortune analyzed the top companies across the continent in partnership with Statista to find the ...

Health and Human Services Secretary Robert F. Kennedy Jr. has announced eight new members to the CDC’s Advisory Committee on ...

Tebipenem's approval in 2026 under SPA could bring Spero $400M+ in milestones & royalties. Read more on why SPRO is a Buy, ...

The release of Pretty Hurts comes two years after GSK collaborated with Lifetime on a short film highlighting the risks ...

Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may ...

After nearly 25 years with Sanofi, Sanjay Gurunathan, M.D., has left for GSK, where he will lead vaccine and infectious ...

FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month.